Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalOperating Expenses
Others
Ratios

Inogen (INGN) EBT (2016 - 2022)

Inogen (INGN) has disclosed EBT for 10 consecutive years, with -$9.4 million as the latest value for Q3 2022.

  • On a quarterly basis, EBT fell 259.15% to -$9.4 million in Q3 2022 year-over-year; TTM through Sep 2022 was $570000.0, a 96.7% decrease, with the full-year FY2021 number at $7.6 million, up 543.67% from a year prior.
  • EBT was -$9.4 million for Q3 2022 at Inogen, down from -$7.9 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $13.7 million in Q2 2019 to a low of -$9.4 million in Q3 2022.
  • A 5-year average of $4.0 million and a median of $5.8 million in 2018 define the central range for EBT.
  • Biggest YoY gain for EBT was 409.93% in 2021; the steepest drop was 729.63% in 2021.
  • Inogen's EBT stood at $5.6 million in 2018, then plummeted by 206.11% to -$6.0 million in 2019, then soared by 121.14% to $1.3 million in 2020, then tumbled by 729.63% to -$7.9 million in 2021, then fell by 19.04% to -$9.4 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's EBT are -$9.4 million (Q3 2022), -$7.9 million (Q4 2021), and $5.9 million (Q3 2021).